Regulators Say New Melanoma Drug is ‘Breakthrough’

Wednesday, 24 Apr 2013 04:50 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
U.S. regulators have granted Merck & Co.'s experimental treatment for advanced melanoma a "breakthrough therapy" designation, which could speed development and regulatory review of the product.
 
The medicine, whose chemical name is lambrolizumab, is also being tested against other forms of cancer. It belongs to a promising class of therapies that harness the body's immune system to find and attack cancer cells. It targets a protein called PD-1, or Programmed Death receptor.
 
The FDA created the "breakthrough therapy" designation earlier this year for medicines deemed likely to demonstrate "substantial improvement" over existing drugs.
 
Although it is intended to provide an easier path for drug development, Merck said it was not yet clear what specific benefits the designation would afford.

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Foam Cups Tied to Cancer

Tuesday, 29 Jul 2014 16:43 PM

An independent panel of scientists has confirmed that styrene - the key chemical component of foam cups and other food s . . .

Generation of Tan Lovers Leads to Spike in Deadly Melanoma

Tuesday, 29 Jul 2014 16:05 PM

Stop sunbathing and using indoor tanning beds, the acting U.S. surgeon general warned in a report released Tuesday that  . . .

Universal Cancer Test Discovered

Monday, 28 Jul 2014 14:55 PM

British researchers have devised a simple blood test that they say can be used to diagnose cancer. The test could enable . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved